Novel Quadrilateral Surface Plate for Acetabular Fracture
- Conditions
- Fracture Dislocation
- Registration Number
- NCT03026868
- Lead Sponsor
- Hebei Medical University Third Hospital
- Brief Summary
The novel plate could be used to manage acetabular fractures involving quadrilateral surface and posterior column, which may lower the intraoperative blood loss and reduce complication rate.
- Detailed Description
Stoppa approach was more minimally invasive than ilioinguinal approach for pelvic and acetabular fractures. Then, Stoppa approach was widely used clinically. For the fragments involving quadrilateral surface, the Kocher-Langenbeck approach was added because the fixation of posterior fragments could not be obtained with reconstruction plate through single Stoppa approach. Novel quadrilateral surface plate was used in this study to examine its fixed role for posterior fragments. Functional outcome and complication were recorded to compare with the results treated with reconstruction plate. If good results were obtained for the patients fixed with quadrilateral surface plate, it was meaningful to popularize the fixed method.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- Over 18 years old
- Fracture involving quadrilateral surface
- Operation was conducted within 14 days
- Fixed with quadrilateral surface plate through Stoppa approach
- Presented with a pathologic acetabular fracture
- Neuropathic arthropathy,dementia and other disease processes which made postoperative compliance unreliable
- Refused to participate
- Follow-up insufficient 12 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method fracture healing time 4 months fracture line disappeared in the radiograph
- Secondary Outcome Measures
Name Time Method complication 1 month wound infection, iatrogenic injury of vessels and nerves, nonunion
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Zhiyong Hou
🇨🇳Shijiazhuang, Hebei, China
Zhiyong Hou🇨🇳Shijiazhuang, Hebei, ChinaZhiyong Hou, M.DContact+8618533112800houzhiyong1234@126.comRuipeng Zhang, M.DPrincipal Investigator